There were 1,354 press releases posted in the last 24 hours and 405,706 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Le virus oncolytique BT-001 de Transgene et BioInvent montre une activité antitumorale prometteuse dans l’étude en cours de Phase I/IIa dans les tumeurs solides résistantes

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.